Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1973 1
1976 1
1977 1
1979 1
1980 1
1981 6
1982 3
1983 5
1984 5
1985 2
1986 7
1987 4
1988 1
1989 5
1990 3
1991 7
1992 7
1993 7
1994 5
1995 8
1996 3
1997 8
1998 7
1999 7
2000 7
2001 6
2002 10
2003 8
2004 10
2005 6
2006 7
2007 10
2008 2
2009 7
2010 15
2011 12
2012 13
2013 13
2014 15
2015 20
2016 17
2017 13
2018 23
2019 26
2020 22
2021 21
2022 15
2023 22
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

384 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Adult malignant schwannoma"
Page 1
Extraskeletal osteosarcoma.
Chung EB, Enzinger FM. Chung EB, et al. Cancer. 1987 Sep 1;60(5):1132-42. doi: 10.1002/1097-0142(19870901)60:5<1132::aid-cncr2820600536>3.0.co;2-l. Cancer. 1987. PMID: 3475157
A retrospective study of 88 cases of extraskeletal osteosarcoma revealed that this tumor affects adults almost exclusively, with a high incidence in patients older than 50 years, and is slightly more common in males (58%) than in female patients. ...Microscopically, the tu …
A retrospective study of 88 cases of extraskeletal osteosarcoma revealed that this tumor affects adults almost exclusively, with a hi …
Management of Central and Peripheral Nervous System Tumors in Patients with Neurofibromatosis.
Brown R. Brown R. Curr Oncol Rep. 2023 Dec;25(12):1409-1417. doi: 10.1007/s11912-023-01451-z. Epub 2023 Oct 31. Curr Oncol Rep. 2023. PMID: 37906356 Review.
Some research suggests that alternative Mek inhibitors and other mixed tyrosine kinase inhibitors may have better efficacy in adults. Vascular endothelial growth factor (VEGF) inhibitor bevacizumab can prolong hearing and delay the need for surgery in NF2 patients with bil …
Some research suggests that alternative Mek inhibitors and other mixed tyrosine kinase inhibitors may have better efficacy in adults. …
Primary bronchial schwannoma: A case report.
Aoyama Y, Miyamoto A, Fujii T, Fujimori S, Tamaoka M, Takai D. Aoyama Y, et al. Medicine (Baltimore). 2022 Oct 7;101(40):e31062. doi: 10.1097/MD.0000000000031062. Medicine (Baltimore). 2022. PMID: 36221358 Free PMC article. Review.
No difference in incidence was observed between right and left bronchial tree. Bronchial schwannoma is sometimes difficult to differentiate from malignant diseases. We should include bronchial schwannoma as one of the differential diagnoses of primary bronchi …
No difference in incidence was observed between right and left bronchial tree. Bronchial schwannoma is sometimes difficult to differe …
Pediatric neurofibrosarcoma.
Neville H, Corpron C, Blakely ML, Andrassy R. Neville H, et al. J Pediatr Surg. 2003 Mar;38(3):343-6; discussion 343-6. doi: 10.1053/jpsu.2003.50105. J Pediatr Surg. 2003. PMID: 12632346 Review.
BACKGROUND/PURPOSE: Neurofibrosarcoma is rare in children, and the natural history and prognostic factors are not well described. ...RESULTS: From 1944 to 2001, 38 patients under the age of 21 were diagnosed with neurofibrosarcoma. Twenty-two were boys. The average …
BACKGROUND/PURPOSE: Neurofibrosarcoma is rare in children, and the natural history and prognostic factors are not well described. ... …
Surgery of the lateral skull base: a 50-year endeavour.
Zanoletti E, Mazzoni A, Martini A, Abbritti RV, Albertini R, Alexandre E, Baro V, Bartolini S, Bernardeschi D, Bivona R, Bonali M, Borghesi I, Borsetto D, Bovo R, Breun M, Calbucci F, Carlson ML, Caruso A, Cayé-Thomasen P, Cazzador D, Champagne PO, Colangeli R, Conte G, D'Avella D, Danesi G, Deantonio L, Denaro L, Di Berardino F, Draghi R, Ebner FH, Favaretto N, Ferri G, Fioravanti A, Froelich S, Giannuzzi A, Girasoli L, Grossardt BR, Guidi M, Hagen R, Hanakita S, Hardy DG, Iglesias VC, Jefferies S, Jia H, Kalamarides M, Kanaan IN, Krengli M, Landi A, Lauda L, Lepera D, Lieber S, Lloyd SLK, Lovato A, Maccarrone F, Macfarlane R, Magnan J, Magnoni L, Marchioni D, Marinelli JP, Marioni G, Mastronardi V, Matthies C, Moffat DA, Munari S, Nardone M, Pareschi R, Pavone C, Piccirillo E, Piras G, Presutti L, Restivo G, Reznitsky M, Roca E, Russo A, Sanna M, Sartori L, Scheich M, Shehata-Dieler W, Soloperto D, Sorrentino F, Sterkers O, Taibah A, Tatagiba M, Tealdo G, Vlad D, Wu H, Zanetti D. Zanoletti E, et al. Acta Otorhinolaryngol Ital. 2019 Jun;39(SUPPL. 1):S1-S146. doi: 10.14639/0392-100X-suppl.1-39-2019. Acta Otorhinolaryngol Ital. 2019. PMID: 31130732 Free PMC article. Review.
The third section was centered on open issues related to the tumor and its treatment. The topic of vestibular schwannoma was investigated with the current debate on observation, hearing preservation surgery, hearing rehabilitation, radiotherapy and the recent efforts to de …
The third section was centered on open issues related to the tumor and its treatment. The topic of vestibular schwannoma was investig …
Sinonasal neurogenic tumours.
Vaideeswar P, Madiwale CV, Kathpal D, Prabhat DP. Vaideeswar P, et al. Indian J Pathol Microbiol. 2002 Apr;45(2):161-3. Indian J Pathol Microbiol. 2002. PMID: 12696731
They were eight in number, three schwannomas, two neurofibromas and three malignant schwannomas with occurrence in a wide age range and no gender predilection. ...The diagnosis of benign neurogenic tumours do not pose difficulty. However, malignant schwannoma …
They were eight in number, three schwannomas, two neurofibromas and three malignant schwannomas with occurrence in a wide age range a …
Plexiform schwannoma.
Megahed M. Megahed M. Am J Dermatopathol. 1994 Jun;16(3):288-93. doi: 10.1097/00000372-199406000-00011. Am J Dermatopathol. 1994. PMID: 7943637 Review.
We report the clinical, histopathologic, and immunohistopathologic features of two cases of plexiform schwannoma. This rare benign tumor is worthy of recognition because it can be misdiagnosed as plexiform neurofibroma. Differentiation from plexiform neurofibroma is import …
We report the clinical, histopathologic, and immunohistopathologic features of two cases of plexiform schwannoma. This rare benign tu …
Malignant peripheral nerve sheath tumour of the oral and maxillofacial region-A systematic review.
Schuch LF, Kirschnick LB, de Arruda JAA, Klein IP, Silveira FM, Vasconcelos ACU, Santos-Silva AR, Lopes MA, Carrard VC, Vargas PA, Martins MAT, Wagner VP, Martins MD. Schuch LF, et al. Oral Dis. 2022 Nov;28(8):2072-2082. doi: 10.1111/odi.13982. Epub 2021 Aug 12. Oral Dis. 2022. PMID: 34333825 Review.
To integrate the available data published on malignant peripheral nerve sheath tumours (MPNST) of the oral and maxillofacial region. ...The lesion showed a predilection for the mandible (n = 18/31.57%) of middle-aged adults (~40.5 years) with a male/female ratio of …
To integrate the available data published on malignant peripheral nerve sheath tumours (MPNST) of the oral and maxillofacial region. …
Intracranial mesenchymal tumor with (novel) COX14::PTEN rearrangement.
d'Amati A, Gianno F, Scuccimarri L, Lastilla M, Messina R, Signorelli F, Zimatore DS, Barresi S, Miele E, Alaggio R, Rossi S, Maiorano E, Ingravallo G, Giangaspero F, Antonelli M. d'Amati A, et al. Acta Neuropathol Commun. 2023 Jun 13;11(1):95. doi: 10.1186/s40478-023-01596-9. Acta Neuropathol Commun. 2023. PMID: 37312212 Free PMC article.
Posterior mediastinal masses.
Saenz NC, Schnitzer JJ, Eraklis AE, Hendren WH, Grier HE, Macklis RM, Shamberger RC. Saenz NC, et al. J Pediatr Surg. 1993 Feb;28(2):172-6. doi: 10.1016/s0022-3468(05)80268-4. J Pediatr Surg. 1993. PMID: 8437074
Of all patients with posterior mediastinal masses, 60% had malignant tumors. Median follow-up for 62 of 63 evaluable patients was 45 months (range, 1 to 289 months). ...There were seven deaths in the series: four from neuroblastoma, two from primitive neuroectodermal tumor …
Of all patients with posterior mediastinal masses, 60% had malignant tumors. Median follow-up for 62 of 63 evaluable patients was 45 …
384 results